Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

371 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium.
Chang K, Pastan I, Willingham MC. Chang K, et al. Among authors: willingham mc. Int J Cancer. 1992 Feb 1;50(3):373-81. doi: 10.1002/ijc.2910500308. Int J Cancer. 1992. PMID: 1735605
Characterization of immunotoxins active against ovarian cancer cell lines.
Pirker R, FitzGerald DJ, Hamilton TC, Ozols RF, Laird W, Frankel AE, Willingham MC, Pastan I. Pirker R, et al. Among authors: willingham mc. J Clin Invest. 1985 Sep;76(3):1261-7. doi: 10.1172/JCI112082. J Clin Invest. 1985. PMID: 3930572 Free PMC article.
Anti-transferrin receptor antibody linked to Pseudomonas exotoxin as a model immunotoxin in human ovarian carcinoma cell lines.
Pirker R, FitzGerald DJ, Hamilton TC, Ozols RF, Willingham MC, Pastan I. Pirker R, et al. Among authors: willingham mc. Cancer Res. 1985 Feb;45(2):751-7. Cancer Res. 1985. PMID: 2981613
Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin.
Pai LH, Wittes R, Setser A, Willingham MC, Pastan I. Pai LH, et al. Among authors: willingham mc. Nat Med. 1996 Mar;2(3):350-3. doi: 10.1038/nm0396-350. Nat Med. 1996. PMID: 8612238 Clinical Trial.
Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude mice.
Pearson JW, FitzGerald DJ, Willingham MC, Wiltrout RH, Pastan I, Longo DL. Pearson JW, et al. Among authors: willingham mc. Cancer Res. 1989 Jul 1;49(13):3562-7. Cancer Res. 1989. PMID: 2499420
Pre-lysosomal divergence of alpha 2-macroglobulin and transferrin: a kinetic study using a monoclonal antibody against a lysosomal membrane glycoprotein (LAMP-1).
Goldenthal KL, Hedman K, Chen JW, August JT, Vihko P, Pastan I, Willingham MC. Goldenthal KL, et al. Among authors: willingham mc. J Histochem Cytochem. 1988 Apr;36(4):391-400. doi: 10.1177/36.4.2450119. J Histochem Cytochem. 1988. PMID: 2450119
A novel fibrillar structure in cultured cells detected by a monoclonal antibody.
Willingham MC, Richert ND, Rutherford AV. Willingham MC, et al. Exp Cell Res. 1987 Aug;171(2):284-95. doi: 10.1016/0014-4827(87)90162-5. Exp Cell Res. 1987. PMID: 3305048
Topology of NGEP, a prostate-specific cell:cell junction protein widely expressed in many cancers of different grade level.
Das S, Hahn Y, Walker DA, Nagata S, Willingham MC, Peehl DM, Bera TK, Lee B, Pastan I. Das S, et al. Among authors: willingham mc. Cancer Res. 2008 Aug 1;68(15):6306-12. doi: 10.1158/0008-5472.CAN-08-0870. Cancer Res. 2008. PMID: 18676855 Free PMC article.
Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers.
Hassan R, Bullock S, Premkumar A, Kreitman RJ, Kindler H, Willingham MC, Pastan I. Hassan R, et al. Among authors: willingham mc. Clin Cancer Res. 2007 Sep 1;13(17):5144-9. doi: 10.1158/1078-0432.CCR-07-0869. Clin Cancer Res. 2007. PMID: 17785569 Clinical Trial.
Mesothelin expression in human lung cancer.
Ho M, Bera TK, Willingham MC, Onda M, Hassan R, FitzGerald D, Pastan I. Ho M, et al. Among authors: willingham mc. Clin Cancer Res. 2007 Mar 1;13(5):1571-5. doi: 10.1158/1078-0432.CCR-06-2161. Clin Cancer Res. 2007. PMID: 17332303
371 results
Jump to page
Feedback